Ireland
--:--IST
Latest
Clinical Trials in France / NCT07405827
Recruiting Observational

French Shoulder Instability Surgery Cohort Study

NCT07405827 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2022-05-01
Last updated
2026-02-12

Condition(s) studied

Shoulder Instability Subluxation BilateralShoulder Instability

Investigational drug(s) / intervention(s)

Shoulder instability surgery

Shoulder instability surgery: Shoulder instability surgery encompasses procedures aimed at restoring stability to the glenohumeral joint following recurrent dislocations or subluxations. Bankart repair (anterior or posterior) involves reattaching the detached labrum to the glenoid rim and tightening the associated capsulolabral structures to restore joint stability. Latarjet (Butée) procedure consists of transferring the coracoid process with its attached muscles to the anterior glenoid, providing a bony and dynamic restraint to prevent recurrent dislocations. These procedures aim to restore joint stability, improve functional outcomes, and enable safe return to sport. They are selected based on the type, direction, and severity of instability, as well as patient-specific factors.

Study summary

This 20-year cohort study follows patients after shoulder instability surgery to evaluate recurrence rates, long-term functional outcomes, return-to-sport rates, and complications.

The goal is to provide insights into the durability and effectiveness of surgical treatment in order to improve patient care.

Eligibility

Sex
ALL
Min age
7 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria Patients undergoing surgical treatment for shoulder instability, including: Bankart repair (anterior or posterior) Latarjet (Butée) procedure Exclusion Criteria Patient refusal

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chirurgie du Sport Paris Île-de-France Region Recruiting

More Chirurgie Du Sport trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07405827 on ClinicalTrials.gov ↗ ← All trials in France